Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types

Other

to

Kalipso Chalkidou

2007-08 Harkness Fellow

Bio: Kalipso Chalkidou, M.D., Ph.D., a 2007-08 Commonwealth Fund Harkness Fellow in Health Care Policy and Practice, is associate director of research and development at NICE, where her work includes disinvestment guidance, evaluation of fast-tracking appraisals of technologies closer to licensing, and the review of social value judgments used by NICE committees. Previous positions include clinical research fellow at the University of Newcastle Medical School and surgical trainee in NHS hospitals in Newcastle and Cambridge. She has authored peer-reviewed articles in basic science, clinical medicine, and health policy, with publications in the BMJ, Health Economics, and the Journal of the Royal Society of Medicine, as well as a book chapter on economic evaluation in public health. Chalkidou graduated with distinction from the Athens Medical School in 2000 and holds a doctorate in prostate cancer from the University of Newcastle upon Tyne. She is an honorary lecturer in health policy at the London School of Hygiene and Tropical Medicine and was recently awarded a two-year grant from the Sasakawa Foundation to study current applications of pharmacoeconomics in Japan.

Placement: Johns Hopkins University

Mentors: Sean Tunis, M.D., M.Sc.; Gerard Anderson, Ph.D.

Project: Developing a Comparative Effectiveness Research Agenda: A Pilot

Description: Chalkidou worked on developing a well-defined, systematic approach to translating an evidence report into a prioritized research agenda. To develop this approach, a comparative effectiveness review (CER) of Percutaneous Coronary Interventions (PCI) and Coronary Artery Bypass Graft Surgery (CABG) was performed. The Centre for Medical Technology Policy then convened a multi-stakeholder workgroup including patients, professionals, researchers, methodologists and consumer representatives to help translate the review into a prioritized list of evidence gaps and research questions.